Two Japanese firms to buy 86% stake in Eu Yan Sang


Eu Yan Sang operates over 170 retail outlets in China, Hong Kong, Macau, Malaysia and Singapore. — The Straits Times

SINGAPORE: Two Japanese firms are providing and outlay of US$594mil to buy out local traditional Chinese medicine maker Eu Yan Sang.

Japanese trading house Mitsui & Co announced on April 4 that a special purpose entity it has set up with Rohto Pharmaceutical will buy around 86% of Eu Yan Sang from Righteous Crane Holding.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Wall St set to open sharply higher on soft jobs data
US job growth slows in April; unemployment rate rises to 3.9%
HSBC has no plans to dispose of further businesses, Chairman says
MJets Air inks aircraft charter agreement with Teleport
Ringgit extends gains to end higher against US dollar
S P Setia to launch Nadi 2, Setia Commerce Square in Setia EcoHill 2, Semenyih this weekend
Farm Price IPO oversubscribed by 91.35 times
XOX to undertake RM303mil capital reduction
Uzma bags contract from Sarawak Shell
Loob Holding eyes Tealive chain expansion into Indonesia by year-end

Others Also Read